AtaiBeckley (ATAI) Shares Outstanding (2020 - 2026)
AtaiBeckley's (ATAI) quarterly Shares Outstanding came in at $240.4 million in Q3 2025, up 13.28% quarter-over-quarter from $212.2 million in Q2 2025.
AtaiBeckley (ATAI) Shares Outstanding (2020 - 2026) Analysis & Trends
AtaiBeckley has disclosed Shares Outstanding across 6 years of filings, most recently posting $240.4 million for Q3 2025.
- Shares Outstanding for Q3 2025 came in at $240.4 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $240.4 million (changed N/A YoY), and the FY2023 annual result was $166.0 million, changed 0.05% from the prior year.
- Shares Outstanding came in at $240.4 million for Q3 2025 at AtaiBeckley, up from $212.2 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $365.6 million in Q1 2026 to a low of $168.0 million in Q4 2024.
- The 5-year median for Shares Outstanding is $166.0 million (2022), against an average of $171.9 million.
- Across the five-year window, Shares Outstanding surged 2164.01% in 2021 and increased 0.05% in 2023, its largest moves.
- AtaiBeckley's Shares Outstanding stood at $160.7 million in 2021, then grew by 3.27% to $165.9 million in 2022, then rose by 0.05% to $166.0 million in 2023, then increased by 0.15% to $166.3 million in 2024, then jumped by 44.6% to $240.4 million in 2025.
- The last three Shares Outstanding figures came in at $365.6 million (Q1 2026), $363.3 million (Q4 2025), and $199.8 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 40.14 Bn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 91.57 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 254.16 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 365.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 365.56 Mn |
| Mar 31, 2026 | 365.56 Mn |
| Mar 31, 2026 | 365.56 Mn |
| Mar 31, 2026 | 365.56 Mn |
| Mar 31, 2026 | 365.56 Mn |
| Mar 31, 2026 | 365.56 Mn |
| Mar 31, 2026 | 365.56 Mn |
| Mar 31, 2026 | 365.56 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Dec 31, 2025 | 363.28 Mn |
| Sep 30, 2025 | 240.44 Mn |
| Sep 30, 2025 | 240.44 Mn |
| Sep 30, 2025 | 240.44 Mn |
| Sep 30, 2025 | 240.44 Mn |